138 related articles for article (PubMed ID: 16775419)
21. Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-κB.
Paul S; Kashyap AK; Jia W; He YW; Schaefer BC
Immunity; 2012 Jun; 36(6):947-58. PubMed ID: 22658522
[TBL] [Abstract][Full Text] [Related]
22. The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.
Stempin CC; Chi L; Giraldo-Vela JP; High AA; Häcker H; Redecke V
J Biol Chem; 2011 Oct; 286(43):37147-57. PubMed ID: 21896478
[TBL] [Abstract][Full Text] [Related]
23. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction.
McAllister-Lucas LM; Inohara N; Lucas PC; Ruland J; Benito A; Li Q; Chen S; Chen FF; Yamaoka S; Verma IM; Mak TW; Núñez G
J Biol Chem; 2001 Aug; 276(33):30589-97. PubMed ID: 11387339
[TBL] [Abstract][Full Text] [Related]
24. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
[TBL] [Abstract][Full Text] [Related]
25. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity.
Zhou H; Du MQ; Dixit VM
Cancer Cell; 2005 May; 7(5):425-31. PubMed ID: 15894263
[TBL] [Abstract][Full Text] [Related]
26. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
[TBL] [Abstract][Full Text] [Related]
27. Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?
Kingeter LM; Schaefer BC
Cell Signal; 2010 Jan; 22(1):9-22. PubMed ID: 19772915
[TBL] [Abstract][Full Text] [Related]
28. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
Kingeter LM; Schaefer BC
J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
[TBL] [Abstract][Full Text] [Related]
29. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Juilland M; Thome M
Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
[TBL] [Abstract][Full Text] [Related]
30. BCL10GFP fusion protein as a substrate for analysis of determinants required for mucosa-associated lymphoid tissue 1 (MALT1)-mediated cleavage.
Jou SY; Chang CC; Wu CH; Chen MR; Tsai CH; Chuang WH; Chen YH; Cheng AL; Doong SL
J Biomed Sci; 2012 Oct; 19(1):85. PubMed ID: 23035874
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type.
Kuper-Hommel MJ; van Krieken JH
Leuk Lymphoma; 2012 Jun; 53(6):1032-45. PubMed ID: 21988643
[TBL] [Abstract][Full Text] [Related]
32. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.
Zhou H; Wertz I; O'Rourke K; Ultsch M; Seshagiri S; Eby M; Xiao W; Dixit VM
Nature; 2004 Jan; 427(6970):167-71. PubMed ID: 14695475
[TBL] [Abstract][Full Text] [Related]
33. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
[TBL] [Abstract][Full Text] [Related]
34. Differential requirement for Malt1 in T and B cell antigen receptor signaling.
Ruland J; Duncan GS; Wakeham A; Mak TW
Immunity; 2003 Nov; 19(5):749-58. PubMed ID: 14614861
[TBL] [Abstract][Full Text] [Related]
35. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
37. Bcl10 can promote survival of antigen-stimulated B lymphocytes.
Tian MT; Gonzalez G; Scheer B; DeFranco AL
Blood; 2005 Sep; 106(6):2105-12. PubMed ID: 15878976
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitination for activation: new directions in the NF-kappaB roadmap.
Lynch OT; Gadina M
Mol Interv; 2004 Jun; 4(3):144-6. PubMed ID: 15210867
[TBL] [Abstract][Full Text] [Related]
39. Bcl10 is an essential regulator for A20 gene expression.
Xu W; Xue L; Sun Y; Henry A; Battle JM; Micault M; Morris SW
J Physiol Biochem; 2013 Dec; 69(4):821-34. PubMed ID: 23677497
[TBL] [Abstract][Full Text] [Related]
40. Study of individual domains contributing to MALT1 dimerization in BCL10-independent and dependent assembly.
Kuo BJ; Lin SC; Tu YF; Huang PH; Lo YC
Biochem Biophys Res Commun; 2024 Jul; 717():150029. PubMed ID: 38714015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
